{"entity":{"type":"insider","cik":"0001865136","url":"/insider/0001865136","json_url":"/insider/0001865136.json","name":"OConnell Daniel Joseph","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":6,"first":"2024-01-19","last":"2026-01-23","span_basis":"filed_date"},"name_variants":[{"name":"OConnell Daniel Joseph","source":"filing","n_filings":6,"first_seen":"2024-01-19","last_seen":"2026-01-23"}],"transactions":[{"id":5835342,"accession":"0001628280-26-003346","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-003346","line_url":"/filing/0001628280-26-003346#line-2","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001865136","owner_name":"OConnell Daniel Joseph","owner_display_name":"OConnell Daniel Joseph","owner_url":"/insider/0001865136","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2689.0,"shares_display":"2,689","price_per_share":1.8838,"price_display":"1.88","price_state":"stated","total_value":5065.5382,"total_display":"5,065.54","total_whole":"5,066","shares_owned_after":881275.0,"shares_owned_after_display":"881,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-23","scope":"insider"},{"id":5835339,"accession":"0001628280-26-003346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-003346","line_url":"/filing/0001628280-26-003346#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001865136","owner_name":"OConnell Daniel Joseph","owner_display_name":"OConnell Daniel Joseph","owner_url":"/insider/0001865136","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9346.0,"shares_display":"9,346","price_per_share":1.8112,"price_display":"1.81","price_state":"stated","total_value":16927.4752,"total_display":"16,927.48","total_whole":"16,927","shares_owned_after":883964.0,"shares_owned_after_display":"883,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-21","filed_date":"2026-01-23","scope":"insider"},{"id":5947774,"accession":"0001628280-26-001895","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-001895","line_url":"/filing/0001628280-26-001895#line-3","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001865136","owner_name":"OConnell Daniel Joseph","owner_display_name":"OConnell Daniel Joseph","owner_url":"/insider/0001865136","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5388.0,"shares_display":"5,388","price_per_share":1.7273,"price_display":"1.73","price_state":"stated","total_value":9306.6924,"total_display":"9,306.69","total_whole":"9,307","shares_owned_after":593510.0,"shares_owned_after_display":"593,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-12","scope":"insider"},{"id":5947771,"accession":"0001628280-26-001895","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-001895","line_url":"/filing/0001628280-26-001895#line-2","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001865136","owner_name":"OConnell Daniel Joseph","owner_display_name":"OConnell Daniel Joseph","owner_url":"/insider/0001865136","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12941.0,"shares_display":"12,941","price_per_share":1.7643,"price_display":"1.76","price_state":"stated","total_value":22831.8063,"total_display":"22,831.81","total_whole":"22,832","shares_owned_after":598898.0,"shares_owned_after_display":"598,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-09","filed_date":"2026-01-12","scope":"insider"},{"id":5947769,"accession":"0001628280-26-001895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-001895","line_url":"/filing/0001628280-26-001895#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001865136","owner_name":"OConnell Daniel Joseph","owner_display_name":"OConnell Daniel Joseph","owner_url":"/insider/0001865136","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8143.0,"shares_display":"8,143","price_per_share":1.8194,"price_display":"1.82","price_state":"stated","total_value":14815.3742,"total_display":"14,815.37","total_whole":"14,815","shares_owned_after":611839.0,"shares_owned_after_display":"611,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-08","filed_date":"2026-01-12","scope":"insider"},{"id":6094670,"accession":"0001628280-26-001263","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-001263","line_url":"/filing/0001628280-26-001263#line-3","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001865136","owner_name":"OConnell Daniel Joseph","owner_display_name":"OConnell Daniel Joseph","owner_url":"/insider/0001865136","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37755.0,"shares_display":"37,755","price_per_share":1.986,"price_display":"1.99","price_state":"stated","total_value":74981.43,"total_display":"74,981.43","total_whole":"74,981","shares_owned_after":619982.0,"shares_owned_after_display":"619,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-07","scope":"insider"},{"id":6094668,"accession":"0001628280-26-001263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-001263","line_url":"/filing/0001628280-26-001263#line-2","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001865136","owner_name":"OConnell Daniel Joseph","owner_display_name":"OConnell Daniel Joseph","owner_url":"/insider/0001865136","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5102.0,"shares_display":"5,102","price_per_share":1.9662,"price_display":"1.97","price_state":"stated","total_value":10031.5524,"total_display":"10,031.55","total_whole":"10,032","shares_owned_after":657737.0,"shares_owned_after_display":"657,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-07","scope":"insider"},{"id":6094664,"accession":"0001628280-26-001263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-001263","line_url":"/filing/0001628280-26-001263#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001865136","owner_name":"OConnell Daniel Joseph","owner_display_name":"OConnell Daniel Joseph","owner_url":"/insider/0001865136","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4649.0,"shares_display":"4,649","price_per_share":1.971,"price_display":"1.97","price_state":"stated","total_value":9163.179,"total_display":"9,163.18","total_whole":"9,163","shares_owned_after":662839.0,"shares_owned_after_display":"662,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":5016753,"accession":"0001576885-25-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001576885-25-000035","line_url":"/filing/0001576885-25-000035#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001865136","owner_name":"OConnell Daniel Joseph","owner_display_name":"OConnell Daniel Joseph","owner_url":"/insider/0001865136","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12619.0,"shares_display":"12,619","price_per_share":1.593,"price_display":"1.59","price_state":"stated","total_value":20102.067,"total_display":"20,102.07","total_whole":"20,102","shares_owned_after":667488.0,"shares_owned_after_display":"667,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider"},{"id":4444496,"accession":"0001576885-25-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001576885-25-000021","line_url":"/filing/0001576885-25-000021#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001865136","owner_name":"OConnell Daniel Joseph","owner_display_name":"OConnell Daniel Joseph","owner_url":"/insider/0001865136","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47778.0,"shares_display":"47,778","price_per_share":1.8392,"price_display":"1.84","price_state":"stated","total_value":87873.2976,"total_display":"87,873.30","total_whole":"87,873","shares_owned_after":454707.0,"shares_owned_after_display":"454,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-07","scope":"insider"},{"id":2428380,"accession":"0001576885-24-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001576885-24-000029","line_url":"/filing/0001576885-24-000029#line-1","is_derivative":false,"issuer_cik":"0001576885","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001576885","owner_cik":"0001865136","owner_name":"OConnell Daniel Joseph","owner_display_name":"OConnell Daniel Joseph","owner_url":"/insider/0001865136","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15200.0,"shares_display":"15,200","price_per_share":3.4706,"price_display":"3.47","price_state":"stated","total_value":52753.12,"total_display":"52,753.12","total_whole":"52,753","shares_owned_after":502485.0,"shares_owned_after_display":"502,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-19","filed_date":"2024-01-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001576885","name":"Acumen Pharmaceuticals, Inc.","url":"/issuer/0001576885","role":"Director, Officer (Chief Executive Officer)","n_filings":6,"first_seen":"2024-01-19","last_seen":"2026-01-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001865136","retrieved_at":"2026-08-25T08:37:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}